title: Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia.
abstract: The deposition, dissolution and transport of salbutamol base (SB) and salbutamol sulfate (SS) inhalation powders were investigated using the Calu-3 air interface cell culture model and Franz diffusion cell. Drug uptake by cells was studied with respect to deposited dose, drug solubility and hydrophobicity. Furthermore, the role of active transport via organic cationic transporters (OCTs) was studied. SB and SS were processed to have similar diameters (3.09 ± 0.06 μm and 3.07 ± 0.03 μm, respectively) and were crystalline in nature. Analysis of drug wetting, dissolution and diffusion using a conventional in vitro Franz cell (incorporating a cell culture support Transwell polyester membrane) showed diffusion of SB to be slower than that of SS (98.57 ± 4.23 μg after 4 h for SB compared to 98.57 ± 4.01 μg after 15 min for SS). Such observations suggest dissolution to be the rate-limiting step. In comparison, the percentage transfer rate using the air interface Calu-3 cell model suggested SB transport to be significantly faster than SS transport (92.02 ± 4.47 μg of SB compared to 63.76 ± 8.84 μg of SS transported over 4 h), indicating that passive diffusion through the cell plays a role in transport. Furthermore, analysis of SB and SS transport, over a range of deposited doses, suggested the transport rate in the Franz diffusion cell to be limited by wetting of the particle and dissolution into the medium. However, for the cell monolayer, the cell membrane properties regulate the diffusion and transport rate. Analysis of the drug transport in the presence of triethylamine (TEA), a known inhibitor of OCTs, resulted in a significant decrease in drug transport, suggesting an active transport mechanism. The presence of OCTs in this cell line was further validated by Western blot analysis. Finally, the transport of SS from a commercial product (Ventolin Rotacaps) was studied and showed good agreement with the model SS system studied here.
authors.affiliation: Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney , Sydney, NSW 2006, Australia.
authors.forename: Mehra
authors.initials: M
authors.lastname: Haghi
authors.forename: Daniela
authors.initials: D
authors.lastname: Traini
authors.forename: Mary
authors.initials: M
authors.lastname: Bebawy
authors.forename: Paul M
authors.initials: PM
authors.lastname: Young
mesh_terms: D000280:Administration, Inhalation; D000420:Albuterol / Q000737:chemistry* / Q000378:metabolism*; D002152:Calorimetry, Differential Scanning; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D008855:Microscopy, Electron, Scanning; D020545:Respiratory Mucosa / Q000378:metabolism*
chemical_list: D000420:Albuterol